Table 2.
Groups | Part | ||||||||
---|---|---|---|---|---|---|---|---|---|
Head | Upper limb | Femur | Trunk | Rib | Pelvis | Spine | Whole body | ||
Control group | Prior to treatment | 0.237 ± 0.010 | 0.153 ± 0.032 | 0.142 ± 0.011 | 0.125 ± 0.009 | 0.113 ± 0.006 | 0.132 ± 0.017 | 0.132 ± 0.008 | 0.149 ± 0.005 |
Posttreatment | 0.243 ± 0.016 | 0.144 ± 0.026 | 0.156 ± 0.012#O | 0.125 ± 0.008# | 0.110 ± 0.007# | 0.134 ± 0.017# | 0.137 ± 0.009# | 0.153 ± 0.007# | |
| |||||||||
GIOP group | Prior to treatment | 0.225 ± 0.015∗ | 0.131 ± 0.031 | 0.127 ± 0.008∗ | 0.110 ± 0.007∗ | 0.099 ± 0.012∗ | 0.113 ± 0.013∗ | 0.108 ± 0.010∗ | 0.132 ± 0.004∗ |
Posttreatment | 0.235 ± 0.021 | 0.123 ± 0.032 | 0.132 ± 0.011 | 0.114 ± 0.007 | 0.102 ± 0.007 | 0.117 ± 0.016 | 0.111 ± 0.015 | 0.135 ± 0.009 | |
| |||||||||
Calcium group | Prior to treatment | 0.221 ± 0.010∗ | 0.147 ± 0.035 | 0.120 ± 0.013∗ | 0.106 ± 0.009∗ | 0.102 ± 0.012∗ | 0.104 ± 0.012∗ | 0.110 ± 0.010∗ | 0.131 ± 0.005∗ |
Posttreatment | 0.237 ± 0.024 | 0.119 ± 0.033 | 0.129 ± 0.019 | 0.113 ± 0.014 | 0.100 ± 0.008 | 0.123 ± 0.018O | 0.125 ± 0.018#O | 0.141 ± 0.013 | |
| |||||||||
PEMF group | Prior to treatment | 0.219 ± 0.006∗ | 0.138 ± 0.009 | 0.120 ± 0.009∗ | 0.107 ± 0.010∗ | 0.100 ± 0.013∗ | 0.101 ± 0.015∗ | 0.110 ± 0.007∗ | 0.133 ± 0.006∗ |
Posttreatment | 0.234 ± 0.024 | 0.112 ± 0.035 | 0.133 ± 0.018O | 0.117 ± 0.008O | 0.104 ± 0.008 | 0.117 ± 0.018O | 0.130 ± 0.013#O | 0.148 ± 0.008#O |
Compared with the control group before treatment, ∗ P < 0.05; compared with the GIOP group after treatment, # P < 0.05; compared with before treatment, O P < 0.05.